240 related articles for article (PubMed ID: 38007403)
21. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
[TBL] [Abstract][Full Text] [Related]
22. The Role of Ferroptosis Signature in Overall Survival and Chemotherapy of Pancreatic Adenocarcinoma.
Wei W; Hu Q; Li W; Li M; Dong S; Peng Y; Yin J; Lu Y; Liu L; Zhao Q
DNA Cell Biol; 2022 Feb; 41(2):116-127. PubMed ID: 34898275
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
24. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
[TBL] [Abstract][Full Text] [Related]
28. Identification of cuproptosis and ferroptosis-related subgroups and development of a signature for predicting prognosis and tumor microenvironment landscape in hepatocellular carcinoma.
Yang BF; Ma Q; Hui Y; Gao XC; Ma DY; Li JX; Pei ZX; Huang BR
Transl Cancer Res; 2023 Dec; 12(12):3327-3345. PubMed ID: 38192999
[TBL] [Abstract][Full Text] [Related]
29. Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma.
Yue Z; Sun J; Shi L
Front Genet; 2022; 13():887542. PubMed ID: 35692844
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma.
Li J; Li W; Wang H; Ni B; Liu Y
Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660936
[TBL] [Abstract][Full Text] [Related]
32. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes.
Yang J; Wei X; Hu F; Dong W; Sun L
Cancer Cell Int; 2022 Jan; 22(1):21. PubMed ID: 35033072
[TBL] [Abstract][Full Text] [Related]
34. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
35. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer.
Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J
Front Oncol; 2021; 11():730716. PubMed ID: 34557413
[TBL] [Abstract][Full Text] [Related]
37. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
Wang C; Wang Z; Zhao Y; Jia R
BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
[TBL] [Abstract][Full Text] [Related]
38. Novel characterization discoveries of ferroptosis-associated molecules in COAD microenvironment based TCGA data.
Baldi S; He Y; Ivanov I; Sun Y; Feng W; Refat M; Mohammed SAD; Adlat S; Tian Z; Wang Y; Gao Y; Tian H
Front Mol Biosci; 2022; 9():1102735. PubMed ID: 36582202
[No Abstract] [Full Text] [Related]
39. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
